Equity
Debts exceed assets in financial year 2025.
Debts exceed assets in financial year 2025.
Lower solvency than 95% of companies in human health. Sector median 63.0% · 21,311 companies.
In July 2024, 7,637 companies had the same profile as Belvicli has now. Each dot stands for 20 companies, two years later.
Another 0.8% stopped without a precise date, possibly only after those two years.
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,637 companies, not a prediction for Belvicli. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
| Company | ||||
|---|---|---|---|---|
| Belvicli Maaseik | €44,097 | -€9,644 | -6.8% | - |
| BDW Neurologie Tremelo | €45,080 | -€3,303 | -16.7% | - |
| Medical Flore Gheysen Ghent | €35,463 | -€594 | 3.6% | - |
| Dr. Caroline Verheyden Hove | €35,489 | -€40,035 | -120.7% | - |
| FILTERLESS Antwerp | €33,762 | -€2,363 | -136.4% | - |
| Health Center Hoeilaart Hoeilaart | €31,707 | -€7,571 | -9.4% | - |
| Chleo Chaumont-Gistoux | €67,881 | €389 | 3.1% | - |
These companies have the same main activity as Belvicli: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €31,700 and €67,900, founded between 2023 and 2025.
Belvicli has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (-€3,017) and a net result of -€13,017.
Its solvency ranks better than 5% of 21,311 sector peers (NACE 86, financial year 2025).
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
See how customers, suppliers and banks see your own company and what to improve first.
If something looks wrong or is missing, please tell us.